(NASDAQ: AGEN) Agenus's forecast annual revenue growth rate of 9.28% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.07%.
Agenus's revenue in 2026 is $114,196,000.On average, 4 Wall Street analysts forecast AGEN's revenue for 2026 to be $9,104,249,733, with the lowest AGEN revenue forecast at $8,730,249,765, and the highest AGEN revenue forecast at $9,390,317,471. On average, 4 Wall Street analysts forecast AGEN's revenue for 2027 to be $4,911,533,460, with the lowest AGEN revenue forecast at $4,718,773,723, and the highest AGEN revenue forecast at $5,055,911,271.
In 2028, AGEN is forecast to generate $6,722,783,818 in revenue, with the lowest revenue forecast at $4,071,761,458 and the highest revenue forecast at $9,479,017,668.